Residual Solvents to USP 467 and 1467

By Butterworth Laboratories

In this white paper, British contract research organisation (CRO) Butterworth Labs explores the intricacies in the recently introduced changes to USP 467 and 1467, Residual Solvents. USP 467 replaces 1226 (Validation of Compendial Procedures). A company’s ability to approach changes openly and embrace them quickly sets them apart from the crowd. Download this free white paper to see how your company can benefit from a CRO that understands and embraces all the latest legislation and guidance for clinical trials.

Enter your details below to view the free Whitepaper

By downloading this case study, you acknowledge that GlobalData may share your information with Butterworth Laboratories and that your personal data will be used as described in their Privacy Policy

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.